Literature DB >> 3954232

In vitro sulfoxidation of albendazole by ovine liver microsomes: assay and frequency of various xenobiotics.

P Galtier, M Alvinerie, P Delatour.   

Abstract

The in vitro biological oxidation of albendazole to its pharmacologically active sulfoxide and its sulfone by ovine liver microsomes has been studied. Sulfoxidation (maximal rate = 0.412 nmole/min/mg of protein, Michaelis constant = 185 X 10(-6) M) was 107 times more potent than formation of albendazole sulfone. The sulfoxidation corresponds to a reduced nicotinamide-adenine dinucleotide phosphate-dependent enzymatic system characterized by a pH optima value around 8. Flavin adenine dinucleotide-containing monooxygenase could be responsible for this S-oxygenation because of the strong inhibitory effect of methimazole. Albendazole sulfoxidase is inhibited competitively by the related anthelmintic drug fenbendazole (inhibitory constant = 243 X 10(-6) M) and noncompetitively by chlorpromazine (inhibitory constant = 135 X 10(-6) M). At high concentration, chloramphenicol, erythromycin, nalidixic acid, and hexobarbital are less active inhibitors, whereas dexamethasone acetate significantly enhances the reaction which is not inhibited by either carbon monoxide, griseofulvin, imidazole, phenylbutazone, or proadifen.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3954232

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  9 in total

1.  Effects of netobimin treatment on the glucose and glycogen contents of Echinococcus granulosus cysts from gerbils.

Authors:  J L Garcia-Llamazares; G Merino-Pelaez; J G Prieto-Fernandez; A I Alvarez de Felipe
Journal:  Vet Res Commun       Date:  2002-01       Impact factor: 2.459

2.  Transplacental transport of netobimin metabolites in ewes.

Authors:  C Cristofol; A Carretero; M Fernandez; M Navarro; J Sautet; J Ruberte; M Arboix
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1995 Jul-Sep       Impact factor: 2.441

3.  Plasma disposition and faecal excretion of netobimin metabolites and enantiospecific disposition of albendazole sulphoxide produced in ewes.

Authors:  C Gokbulut; V Y Cirak; B Senlik
Journal:  Vet Res Commun       Date:  2006-10       Impact factor: 2.459

4.  Study of the in vitro bioactivation of albendazole in human liver microsomes and hepatoma cell lines.

Authors:  S Rolin; H Souhaili-el Amri; A M Batt; M Levy; D Bagrel; G Siest
Journal:  Cell Biol Toxicol       Date:  1989-01       Impact factor: 6.691

5.  Aspects of the pharmacokinetics of albendazole sulphoxide in sheep.

Authors:  A Goudah
Journal:  Vet Res Commun       Date:  2003-10       Impact factor: 2.459

6.  Albendazole enantiomeric metabolism and binding to cytosolic proteins in the liver fluke Fasciola hepatica.

Authors:  H Solana; S Scarcella; G Virkel; C Ceriani; J Rodríguez; C Lanusse
Journal:  Vet Res Commun       Date:  2008-08-26       Impact factor: 2.459

7.  Improvement of Albendazole Bioavailability with Menbutone Administration in Sheep.

Authors:  Raquel Diez; M Jose Diez; Juan J Garcia; Jose M Rodríguez; Cristina Lopez; Nelida Fernandez; Matilde Sierra; Ana M Sahagun
Journal:  Animals (Basel)       Date:  2022-02-14       Impact factor: 2.752

8.  Pharmacological characterization of geraniol in sheep and its potential use in the control of gastrointestinal nematodes.

Authors:  María Victoria Miró; Livio Martins Costa-Júnior; Luis Ignacio Alvarez; Carlos Lanusse; Guillermo Virkel; Adrián Lifschitz
Journal:  Vet Anim Sci       Date:  2022-09-14

9.  Exploring the potential of flubendazole in filariasis control: evaluation of the systemic exposure for different pharmaceutical preparations.

Authors:  Laura Ceballos; Charles Mackenzie; Timothy Geary; Luis Alvarez; Carlos Lanusse
Journal:  PLoS Negl Trop Dis       Date:  2014-05-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.